Function of 27-Hydroxycholesterol in Various Tissues and Diseases |
Shim, Wan-Seog
(Department of Convergence Medicine, Pusan National University School of Medicine)
Lee, Chanhee (Department of Convergence Medicine, Pusan National University School of Medicine) Azamov, Bakhovuddin (Department of Convergence Medicine, Pusan National University School of Medicine) Kim, Koanhoi (Department of Pharmacology, Pusan National University School of Medicine) Lee, Dongjun (Department of Convergence Medicine, Pusan National University School of Medicine) Song, Parkyong (Department of Convergence Medicine, Pusan National University School of Medicine) |
1 | Bieghs, V., Hendrikx, T., van Gorp, P. J., Verheyen, F., Guichot, Y. D., Walenbergh, S. M., Jeurissen, M. L., Gijbels, M., Rensen, S. S., Bast, A., Plat, J., Kalhan, S. C., Koek, G. H., Leitersdorf, E., Hofker, M. H., Lutjohann, D. and ShiriSverdlov, R. 2013. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice. Gastroenterology 144, 167-178 e161. DOI |
2 | Brown, M. S. and Goldstein, J. L. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340. DOI |
3 | Asghari, A., Ishikawa, T., Hiramitsu, S., Lee, W. R., Umetani, J., Bui, L., Korach, K. S. and Umetani, M. 2019. 27-Hydroxycholesterol promotes adiposity and mimics adipogenic diet-induced inflammatory signaling. Endocrinology 160, 2485-2494. DOI |
4 | Ouchi, N., Parker, J. L., Lugus, J. J. and Walsh, K. 2011. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97. DOI |
5 | Li, D., Cui, Y., Wang, X., Liu, F. and Li, X. 2021. Apple polyphenol extract improves high-fat diet-induced hepatic steatosis by regulating bile acid synthesis and gut microbiota in C57BL/6 male mice. J. Agric. Food Chem. 69, 6829-6841. DOI |
6 | Doria, M., Maugest, L., Moreau, T., Lizard, G. and Vejux, A. 2016. Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease. Free Radic. Biol. Med. 101, 393-400. DOI |
7 | Bjorkhem, I. 2009. Are side-chain oxidized oxysterols regulators also in vivo? J. Lipid Res. 50 Suppl, S213-218. DOI |
8 | Ding, X., Zhang, W., Li, S. and Yang, H. 2019. The role of cholesterol metabolism in cancer. Am. J. Cancer Res. 9, 219-227. |
9 | Garcia-Cruset, S., Carpenter, K. L., Guardiola, F., Stein, B. K. and Mitchinson, M. J. 2001. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic. Res. 35, 31-41. DOI |
10 | Kim, B. Y., Son, Y., Cho, H. R., Lee, D., Eo, S. K. and Kim, K. 2021. 27-Hydroxycholesterol induces macrophage gene expression via LXR-dependent and -independent mechanisms. Kor. J. Physiol. Pharmacol. 25, 111-118. DOI |
11 | Li, D., Long, W., Huang, R., Chen, Y. and Xia, M. 2018. 27- Hydroxycholesterol inhibits sterol regulatory element-binding protein 1 activation and hepatic lipid accumulation in mice. Obesity (Silver Spring) 26, 713-722. DOI |
12 | Dietschy, J. M. and Turley, S. D. 2004. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375-1397. DOI |
13 | Zhou, Z., Moore, T. M., Drew, B. G., Ribas, V., Wanagat, J., Civelek, M., Segawa, M., Wolf, D. M., Norheim, F., Seldin, M. M., Strumwasser, A. R., Whitney, K. A., Lester, E., Reddish, B. R., Vergnes, L., Reue, K., Rajbhandari, P., Tontonoz, P., Lee, J., Mahata, S. K., Hewitt, S. C., Shirihai, O., Gastonbury, C., Small, K. S., Laakso, M., Jensen, J., Lee, S., Drevon, C. A., Korach, K. S., Lusis, A. J. and Hevener, A. L. 2020. Estrogen receptor alpha controls metabolism in white and brown adipocytes by regulating Polg1 and mitochondrial remodeling. Sci. Transl. Med. 12, eaax8096. DOI |
14 | Li, J., Daly, E., Campioli, E., Wabitsch, M. and Papadopoulos, V. 2014. De novo synthesis of steroids and oxysterols in adipocytes. J. Biol. Chem. 289, 747-764. DOI |
15 | Liao, J. K. 2005. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am. J. Cardiol. 96, 24F-33F. |
16 | Mutemberezi, V., Guillemot-Legris, O. and Muccioli, G. G. 2016. Oxysterols: From cholesterol metabolites to key mediators. Prog. Lipid Res. 64, 152-169. DOI |
17 | Nohturfft, A., Yabe, D., Goldstein, J. L., Brown, M. S. and Espenshade, P. J. 2000. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell 102, 315-323. DOI |
18 | Escher, G., Krozowski, Z., Croft, K. D. and Sviridov, D. 2003. Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. J. Biol. Chem. 278, 11015-11019. DOI |
19 | Shimano, H., Yahagi, N., Amemiya-Kudo, M., Hasty, A. H., Osuga, J., Tamura, Y., Shionoiri, F., Iizuka, Y., Ohashi, K., Harada, K., Gotoda, T., Ishibashi, S. and Yamada, N. 1999. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 274, 35832-35839. DOI |
20 | Piccinin, E., Villani, G. and Moschetta, A. 2019. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. Nat. Rev. Gastroenterol. Hepatol. 16, 160-174. DOI |
21 | Sun, L. P., Li, L., Goldstein, J. L. and Brown, M. S. 2005. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J. Biol. Chem. 280, 26483-26490. DOI |
22 | Vogeli, I., Jung, H. H., Dick, B., Erickson, S. K., Escher, R., Funder, J. W., Frey, F. J. and Escher, G. 2013. Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo. J. Endocrinol. 219, 119-129. DOI |
23 | Wolf, G. 1999. The role of oxysterols in cholesterol homeostasis. Nutr. Rev. 57, 196-198. DOI |
24 | Meaney, S., Hassan, M., Sakinis, A., Lutjohann, D., von Bergmann, K., Wennmalm, A., Diczfalusy, U. and Bjorkhem, I. 2001. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. J. Lipid Res. 42, 70-78. DOI |
25 | Matsuda, M., Korn, B. S., Hammer, R. E., Moon, Y. A., Komuro, R., Horton, J. D., Goldstein, J. L., Brown, M. S. and Shimomura, I. 2001. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 15, 1206-1216. DOI |
26 | Nelson, E. R., Wardell, S. E., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P. M., Sondhi, V., Umetani, M., Geradts, J. and McDonnell, D. P. 2013. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 342, 1094-1098. DOI |
27 | Horton, J. D., Goldstein, J. L. and Brown, M. S. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131. DOI |
28 | Iuliano, L. 2011. Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem. Phys. Lipids 164, 457-468. DOI |
29 | Lorbek, G., Lewinska, M. and Rozman, D. 2012. Cytochrome P450s in the synthesis of cholesterol and bile acids--from mouse models to human diseases. FEBS J. 279, 1516-1533. DOI |
30 | Manrique, C., Lastra, G., Habibi, J., Mugerfeld, I., Garro, M. and Sowers, J. R. 2012. Loss of estrogen receptor alpha signaling leads to insulin resistance and obesity in young and adult female mice. Cardiorenal. Med. 2, 200-210. DOI |
31 | Miziorko, H. M. 2011. Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch. Biochem. Biophys. 505, 131-143. DOI |
32 | Wang, Y., An, Y., Ma, W., Yu, H., Lu, Y., Zhang, X., Wang, Y., Liu, W., Wang, T. and Xiao, R. 2020. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction. J. Neuroinflammation 17, 199. DOI |
33 | Russell, D. W. 2009. Fifty years of advances in bile acid synthesis and metabolism. J. Lipid Res. 50 Suppl, S120-125. DOI |
34 | Sharma, B. and Agnihotri, N. 2019. Role of cholesterol homeostasis and its efflux pathways in cancer progression. J. Steroid Biochem. Mol. Biol. 191, 105377. DOI |
35 | Nofer, J. R. 2012. Estrogens and atherosclerosis: insights from animal models and cell systems. J. Mol. Endocrinol. 48, R13-29. DOI |
36 | Nordlie, R. C., Foster, J. D. and Lange, A. J. 1999. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19, 379-406. DOI |
37 | Umetani, M., Domoto, H., Gormley, A. K., Yuhanna, I. S., Cummins, C. L., Javitt, N. B., Korach, K. S., Shaul, P. W. and Mangelsdorf, D. J. 2007. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13, 1185-1192. DOI |
38 | Umetani, M., Ghosh, P., Ishikawa, T., Umetani, J., Ahmed, M., Mineo, C. and Shaul, P. W. 2014. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Cell. Metab. 20, 172-182. DOI |
39 | Wahlstrom, A., Sayin, S. I., Marschall, H. U. and Backhed, F. 2016. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell. Metab. 24, 41-50. DOI |
40 | Yang, T., Espenshade, P. J., Wright, M. E., Yabe, D., Gong, Y., Aebersold, R., Goldstein, J. L. and Brown, M. S. 2002. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489-500. DOI |
41 | Zhu, D., Shen, Z., Liu, J., Chen, J., Liu, Y., Hu, C., Li, Z. and Li, Y. 2016. The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-in duced angiogenesis in human breast cancer cells. Toxicol. Lett. 264, 79-86. DOI |
42 | Shirouchi, B., Kashima, K., Horiuchi, Y., Nakamura, Y., Fujimoto, Y., Tong, L. T. and Sato, M. 2017. 27-Hydroxycholesterol suppresses lipid accumulation by down-regulating lipogenic and adipogenic gene expression in 3T3-L1 cells. Cytotechnology 69, 485-492. DOI |
43 | Spann, N. J. and Glass, C. K. 2013. Sterols and oxysterols in immune cell function. Nat. Immunol. 14, 893-900. DOI |